Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Corcept Therapeutics (CORT) over the last 9 years, with Q3 2025 value amounting to 0.12%.

  • Corcept Therapeutics' Return on Invested Capital fell 700.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.2% for FY2024, which is 200.0% up from last year.
  • As of Q3 2025, Corcept Therapeutics' Return on Invested Capital stood at 0.12%, which was down 700.0% from 0.16% recorded in Q2 2025.
  • Corcept Therapeutics' Return on Invested Capital's 5-year high stood at 0.28% during Q1 2022, with a 5-year trough of 0.12% in Q3 2025.
  • In the last 5 years, Corcept Therapeutics' Return on Invested Capital had a median value of 0.19% in 2021 and averaged 0.2%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first skyrocketed by 1000bps in 2022, then tumbled by -1100bps in 2023.
  • Corcept Therapeutics' Return on Invested Capital (Quarter) stood at 0.24% in 2021, then dropped by -18bps to 0.2% in 2022, then decreased by -6bps to 0.19% in 2023, then decreased by -4bps to 0.18% in 2024, then tumbled by -32bps to 0.12% in 2025.
  • Its Return on Invested Capital stands at 0.12% for Q3 2025, versus 0.16% for Q2 2025 and 0.16% for Q1 2025.